These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9876937)

  • 21. Gene polymorphism in apolipoprotein E and presenilin-1 in patients with late-onset Alzheimer's disease.
    Cui T; Zhou X; Jin W; Zheng F; Cao X
    Chin Med J (Engl); 2000 Apr; 113(4):340-4. PubMed ID: 11775232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of polymorphisms in the presenilin-1 gene and the butyrylcholinesterase gene as risk factors in sporadic Alzheimer's disease.
    Tilley L; Morgan K; Grainger J; Marsters P; Morgan L; Lowe J; Xuereb J; Wischik C; Harrington C; Kalsheker N
    Eur J Hum Genet; 1999 Sep; 7(6):659-63. PubMed ID: 10482954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. APOE-epsilon4 and APOE -491A polymorphisms in individuals with subjective memory loss.
    Laws SM; Clarnette RM; Taddei K; Martins G; Paton A; Hallmayer J; Almeida OP; Groth DM; Gandy SE; Förstl H; Martins RN
    Mol Psychiatry; 2002; 7(7):768-75. PubMed ID: 12192621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Sp1/Egr1-tandem repeat polymorphism in the 5-lipoxygenase gene promoter is not associated with late onset Alzheimer disease.
    Alvarez V; González P; Corao AI; Menéndez M; Lahoz CH; Martínez C; Calatayud M; Morales B; Coto E
    Alzheimer Dis Assoc Disord; 2008; 22(2):177-80. PubMed ID: 18525291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein E epsilon4 and age at onset of sporadic and familial Alzheimer disease in Caribbean Hispanics.
    Olarte L; Schupf N; Lee JH; Tang MX; Santana V; Williamson J; Maramreddy P; Tycko B; Mayeux R
    Arch Neurol; 2006 Nov; 63(11):1586-90. PubMed ID: 17101827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A polymorphism of the interleukin-1 beta gene at position +3953 influences progression and neuro-pathological hallmarks of Alzheimer's disease.
    Licastro F; Veglia F; Chiappelli M; Grimaldi LM; Masliah E
    Neurobiol Aging; 2004 Sep; 25(8):1017-22. PubMed ID: 15212826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic association of alpha2-Heremans-Schmid glycoprotein polymorphism with late-onset Alzheimer's disease in Italians.
    Geroldi D; Minoretti P; Bianchi M; Di Vito C; Reino M; Bertona M; Emanuele E
    Neurosci Lett; 2005 Oct; 386(3):176-8. PubMed ID: 16002217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apolipoprotein E epsilon4 allele frequency in elderly depressed patients with and without cerebrovascular disease.
    Traykov L; Bayle AC; Latour F; Lenoir H; Seux ML; Hanon O; Péquignot R; Bert P; Moulin F; Cantegreil I; Wenisch E; Batouche F; Mehrabian S; Rotrou Jd; Rigaud AS
    J Neurol Sci; 2007 Jun; 257(1-2):280-3. PubMed ID: 17337010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ageing matters. Genetic link to Alzheimer's.
    Isaacs R; Roquew P
    Nurs Times; 1995 Apr 26-May 2; 91(17):61-3. PubMed ID: 7753666
    [No Abstract]   [Full Text] [Related]  

  • 30. Genetic determinants of Alzheimer disease.
    St George-Hyslop P
    Prog Clin Biol Res; 1995; 393():139-45. PubMed ID: 8545447
    [No Abstract]   [Full Text] [Related]  

  • 31. Apolipoprotein E4 and Alzheimer's disease pathology in Lewy body disease and in other beta-amyloid-forming diseases.
    Pickering-Brown SM; Mann DM; Bourke JP; Roberts DA; Balderson D; Burns A; Byrne J; Owen F
    Lancet; 1994 May; 343(8906):1155. PubMed ID: 7818636
    [No Abstract]   [Full Text] [Related]  

  • 32. [Apolipoprotein E and Alzheimer disease (reply)].
    Jiménez Escrig A; Barón M; Gobernado JM
    Rev Clin Esp; 1997 Sep; 197(9):659. PubMed ID: 9411578
    [No Abstract]   [Full Text] [Related]  

  • 33. The influence of apolipoprotein E isotypes on Alzheimer's disease pathology in 40 cases of Down's syndrome.
    Wisniewski T; Morelli L; Wegiel J; Levy E; Wisniewski HM; Frangione B
    Ann Neurol; 1995 Jan; 37(1):136-8. PubMed ID: 7818249
    [No Abstract]   [Full Text] [Related]  

  • 34. Apolipoprotein E and functional illness in the elderly.
    Holmes C
    Int Psychogeriatr; 1998 Mar; 10(1):3-6. PubMed ID: 9629519
    [No Abstract]   [Full Text] [Related]  

  • 35. Apolipoprotein E, Alzheimer's disease and Down's syndrome.
    Prasher VP; Haque MS
    Br J Psychiatry; 2000 Nov; 177():469-70. PubMed ID: 11060007
    [No Abstract]   [Full Text] [Related]  

  • 36. Alzheimer's disease, Down's syndrome, and chromosome segregation.
    Potter H; Geller LN
    Lancet; 1996 Jul; 348(9019):66. PubMed ID: 8691961
    [No Abstract]   [Full Text] [Related]  

  • 37. Apolipoprotein E genes in Lewy body and Parkinson's disease.
    Benjamin R; Leake A; Edwardson JA; McKeith IG; Ince PG; Perry RH; Morris CM
    Lancet; 1994 Jun; 343(8912):1565. PubMed ID: 7911882
    [No Abstract]   [Full Text] [Related]  

  • 38. ApoE genotype and Down's syndrome.
    Hardy J; Crook R; Perry R; Raghavan R; Roberts G
    Lancet; 1994 Apr; 343(8903):979-80. PubMed ID: 7909036
    [No Abstract]   [Full Text] [Related]  

  • 39. Psychiatric genetics: what to expect.
    Hallmayer JF
    Curr Psychiatry Rep; 2004 Jun; 6(3):149-50. PubMed ID: 15142466
    [No Abstract]   [Full Text] [Related]  

  • 40. APOE polymorphisms and late-onset Alzheimer disease: the importance of ethnicity.
    Kukull WA; Martin GM
    JAMA; 1998 Mar; 279(10):788-9. PubMed ID: 9508157
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.